These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28394802)

  • 1. Identification of DAB2 and Intelectin-1 as Novel Positive Immunohistochemical Markers of Epithelioid Mesothelioma by Transcriptome Microarray Analysis for Its Differentiation From Pulmonary Adenocarcinoma.
    Kuraoka M; Amatya VJ; Kushitani K; Mawas AS; Miyata Y; Okada M; Kishimoto T; Inai K; Nishisaka T; Sueda T; Takeshima Y
    Am J Surg Pathol; 2017 Aug; 41(8):1045-1052. PubMed ID: 28394802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX6 is a Novel Immunohistochemical Marker for Differential Diagnosis of Epithelioid Mesothelioma From Lung Adenocarcinoma.
    Kambara T; Amatya VJ; Kushitani K; Suzuki R; Fujii Y; Kai Y; Miyata Y; Okada M; Takeshima Y
    Am J Surg Pathol; 2020 Sep; 44(9):1259-1265. PubMed ID: 32496433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of SOX6 and DAB2 for the Diagnosis of Malignant Mesothelioma.
    Naso JR; Cheung S; Ionescu DN; Churg A
    Am J Surg Pathol; 2021 Sep; 45(9):1245-1251. PubMed ID: 33782226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma.
    Nakagiri T; Amatya VJ; Kushitani K; Kambara T; Aoe K; Endo I; Miyata Y; Okada M; Takeshima Y
    Am J Surg Pathol; 2024 Feb; 48(2):140-149. PubMed ID: 37899530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucin 21 is a novel, negative immunohistochemical marker for epithelioid mesothelioma for its differentiation from lung adenocarcinoma.
    Kai Y; Amatya VJ; Kushitani K; Kambara T; Suzuki R; Tsutani Y; Miyata Y; Okada M; Takeshima Y
    Histopathology; 2019 Mar; 74(4):545-554. PubMed ID: 30329165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Glut-1 and Koc markers in the differential diagnosis of reactive mesothelial hyperplasia, malignant mesothelioma and pulmonary adenocarcinoma.
    Üçer Ö; Dağli AF; Kiliçarslan A; Artaş G
    Turk Patoloji Derg; 2013; 29(2):94-100. PubMed ID: 23661345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of intelectin overexpression in malignant pleural mesothelioma by serial analysis of gene expression (SAGE).
    Wali A; Morin PJ; Hough CD; Lonardo F; Seya T; Carbone M; Pass HI
    Lung Cancer; 2005 Apr; 48(1):19-29. PubMed ID: 15777968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific expression of human intelectin-1 in malignant pleural mesothelioma and gastrointestinal goblet cells.
    Washimi K; Yokose T; Yamashita M; Kageyama T; Suzuki K; Yoshihara M; Miyagi Y; Hayashi H; Tsuji S
    PLoS One; 2012; 7(7):e39889. PubMed ID: 22768319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type.
    Comin CE; Dini S; Novelli L; Santi R; Asirelli G; Messerini L
    Am J Surg Pathol; 2006 Apr; 30(4):463-9. PubMed ID: 16625092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
    Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
    Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung.
    Mawas AS; Amatya VJ; Kushitani K; Kai Y; Miyata Y; Okada M; Takeshima Y
    Sci Rep; 2018 Jan; 8(1):134. PubMed ID: 29317712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary adenocarcinoma simulating malignant mesothelioma.
    Tang P; Vatsia SK; Teichberg S; Kahn E
    Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma.
    Chaouche-Mazouni S; Scherpereel A; Zaamoum R; Mihalache A; Amir ZC; Lebaïli N; Delaire B; Gosset P
    Ann Diagn Pathol; 2015 Aug; 19(4):193-7. PubMed ID: 25935651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretion of intelectin-1 from malignant pleural mesothelioma into pleural effusion.
    Tsuji S; Tsuura Y; Morohoshi T; Shinohara T; Oshita F; Yamada K; Kameda Y; Ohtsu T; Nakamura Y; Miyagi Y
    Br J Cancer; 2010 Aug; 103(4):517-23. PubMed ID: 20628387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
    Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
    Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
    Amatya VJ; Kushitani K; Kai Y; Suzuki R; Miyata Y; Okada M; Takeshima Y
    Mod Pathol; 2018 May; 31(5):809-815. PubMed ID: 29327712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 2003 Aug; 27(8):1031-51. PubMed ID: 12883236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma.
    Amatya VJ; Takeshima Y; Kohno H; Kushitani K; Yamada T; Morimoto C; Inai K
    Histopathology; 2009 Jul; 55(1):10-9. PubMed ID: 19614762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma.
    McGregor SM; McElherne J; Minor A; Keller-Ramey J; Dunning R; Husain AN; Vigneswaran W; Fitzpatrick C; Krausz T
    Hum Pathol; 2017 Feb; 60():86-94. PubMed ID: 27771374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal lamina reduplication in malignant epithelioid pleural mesothelioma.
    Di Muzio M; Spoletini L; Strizzi L; Procopio A; Tassi G; Casalini A; Modesti A
    Ultrastruct Pathol; 1998; 22(6):467-75. PubMed ID: 9891926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.